Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use

NCT02307721 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Drug Overdose

Interventions

DRUG: Intranasal naloxone
DRUG: Intramuscular naloxone
DRUG: Remifentanil
DEVICE: Aptar Unidose

Sponsor

Norwegian University of Science and Technology

Collaborators

[object Object]